Headlines

Executive Summary: Supporting mRNA Development With Quantitative Expression Analysis

Executive Summary: Supporting mRNA Development With Quantitative Expression Analysis

Quantitative protein expression analysis is essential for advancing mRNA therapeutics, providing the data needed to confirm effective and targeted protein production. This article explores key assay development strategies, analytical challenges, and the application of advanced liquid chromatography-mass spectrometry (LC-MS) techniques to achieve precise and reproducible quantitation of proteins expressed from mRNA therapies.

Download Executive Summary

Read this article to learn more about:

  • The regulatory significance and carcinogenic risk of nitrosamines and NDSRIs in pharmaceuticals.
  • Key analytical challenges in detecting nitrosamines at parts-per-trillion (PPT) levels and how LC-MS/MS addresses them.
  • Real-world case studies to implement sensitive, reproducible, and compliant workflows for nitrosamine analysis.
     
     
Quantitative Expression Analysis

Yes, I want to receive marketing communications from SCIEX.

By submitting your information, you agree that SCIEX may collect and further process your personal data in accordance with its Privacy Policy.
You may object to receiving further information at any time.

By downloading this content, you agree to MJH Life Sciences® Terms and Conditions, Privacy Policy, and understand your data will be used by MJH and its affiliates for amongst other things, alerting you to other services or products that you may be interested in, and may be shared with or sold to third parties for their use, including possible contact with you through email or other communications, consistent with their respective privacy policy. If you do not agree to have your data used in this way, please contact info@mjhassoc.com.